Drug allergy: the physician's and the patient's perspective

28th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology -- JUN 06-10, 2009 -- Warsaw, POLANDKalpaklioglu, A. Fusun/0000-0002-6548-6932WOS: 000266171501010…European Acad Allergy & Clin Immuno

Intranasal Corticosteroid Theraphy in Idiopathic Rhinitis: a Comparative Study with Allergic Rhinitis

American-Academy-of-Allergy-Asthma-and-Immunology Annual Meeting -- MAR 18-22, 2011 -- San Francisco, CAWOS: 000295846400777…Amer Acad Allergy Asthma & Immuno

Helicobacter pylori positivity in allergic inflammation

26th Congress of the European-Academy-of-Allergology-and-Clinical-Immunology -- JUN 09-13, 2007 -- Goteborg, SWEDENKalpaklioglu, A. Fusun/0000-0002-6548-6932WOS: 000246800000742…European Acad Allergology & Clin Immuno

Allergic rhinitis versus nonallergic rhinitis: is it possible to find the differences/similarities between the two pictures?

27th Congress of the European-Academy-of-Allergology-and-Clinical-Immunology -- JUN 07-11, 2008 -- Barcelona, SPAINKalpaklioglu, A. Fusun/0000-0002-6548-6932WOS: 000256235601617…European Acad Allergol & Clinical Immuno

Rationale of autologous serum skin test in acute vs chronic urticaria

Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI) -- MAY 26-30, 2018 -- Munich, GERMANYWOS: 000441690400036…European Acad Allergy & Clin Immuno

Response to omalizumab in urticaria & asthma: "a life-time together?"

Congress of the European-Academy-of-Allergy-and-Clinical-Immunology -- JUN 17-21, 2017 -- Helsinki, FINLANDKalpaklioglu, A. Fusun/0000-0002-6548-6932WOS: 000408773103067…European Acad Allergy & Clin Immuno

Efficacy and safety of H1-antihistamines: An update

PubMed: 23173575H1-antihistamines are inverse agonists that combine with and stabilize inactive conformation of H1-receptors. Thus they interfere with actions of histamine at H1-receptors. They are widely used for treatment of allergic rhinitis, allergic conjunctivitis, urticaria, coughs, colds and insomnia. H1-antihistamines are classified as older 'first generation' and newer 'second generation'. First generation H1-antihistamines have poor receptor H1-receptor selectivity, and cross blood-brain-barrier. They have a lot of adverse events such as anti-muscarinic, anti-?-adrenergic, anti-serotonin, and sedative effects. In contrast, second generation H1-antihistamines were highly selective for the histamine H1-receptor, do not cross the blood brain barrier, and have minimal adverse events. The risks of first-generation H1-antihistamines have been clearly underestimated, particularly when purchased as nonprescribed over the counter medications by public. This review summarizes curent literature to evaluate antihistamines including their mechanism, indications and side-effects. © 2012 Bentham Science Publishers

Evaluation of IgE test results in clinical practice

Meeting of the European-Academy-of-Allergy-and-Clinical-Immunology -- JUN 11-15, 2016 -- Vienna, AUSTRIAKalpaklioglu, A. Fusun/0000-0002-6548-6932WOS: 000383679802203…European Acad Allergy & Clin Immuno

Evaluation of quality of life: Impact of allergic rhinitis on asthma

WOS: 000256389000004PubMed: 18564627Background: Health-related quality of Life (HRQOL) has been considered an important variable to be managed in airway diseases, Allergy and asthma can reduce HRQOL as a result of profound physical and psychosocial complications. Most patients with asthma also suffer from rhinitis, which also impairs quality of life. However, the impact of allergic rhinitis on asthmatic patients has not been investigated. Objective: Our objective was to evaluate HRQOL in patients with asthma alone, allergic rhinitis alone, or both diseases. Methods: We compared HRQOL in 316 patients with both diseases or either asthma or rhinitis using the Short Form-36 questionnaire. Data were also collected on patients' sociodemographic characteristics, atopic state, body mass index (BMI), and education. Results: A total of 232 patients with allergic rhinitis, 40 with asthma, and 44 with both diseases were enrolled. The mean (SD) age was 32 (13) years and 65% were females. HRQL was significantly lower in patients with asthma, with or without rhinitis, than in those with allergic rhinitis alone. Female sex, older age, increased BMI and less educational status were found to be the major determinants of impaired quality of life in patients with allergic rhinitis or asthma. Conclusions: The impact of rhinitis on asthma seems to play a minor role in HRQOL